Skip to main content
Top
Published in: BMC Psychiatry 1/2019

Open Access 01-12-2019 | Schizophrenia | Research article

Change in smoking cessation stage over 1 year in patients with schizophrenia: a follow up study in Japan

Authors: Yuji Higuchi, Masaki Fujiwara, Naoki Nakaya, Maiko Fujimori, Chinatsu Hayashibara, Ryuhei So, Ikuta Shinkawa, Kojiro Sato, Yuji Yada, Masafumi Kodama, Hiroshi Takenaka, Yoshiki Kishi, Kyoko Kakeda, Yosuke Uchitomi, Norihito Yamada, Masatoshi Inagaki

Published in: BMC Psychiatry | Issue 1/2019

Login to get access

Abstract

Background

We performed a follow up study about willingness and behaviors to quit smoking among smokers with schizophrenia in Japan.

Methods

Participants were outpatients with schizophrenia aged 20–69 years who had been visiting the hospital for ≥1 year as of April 1, 2016, and had visited the hospital more than once in the previous 6 months. A baseline survey on smoking behaviors including current smoking status and smoking cessation stage, was administered in 420 participants that were randomly extracted from a patient pool (n = 680) in 2016, and a follow-up survey was administered in 2017. We calculated the distribution and change in smoking cessation stage, number of smokers and nonsmokers after 1 year, and quitting rate from a naturalistic 1-year smoking-cessation follow up.

Results

The number of baseline respondents was 350; 113 current smokers and 68 former smokers. Among the 113 current smokers, 104 (92.0%) were followed for 1 year, 79 (70.0%) were interested in smoking cessation, and only 7 had received smoking cessation treatments at baseline. Among the tracked 104 participants, only 6 (5.8%) stopped smoking after 1 year. Among the 25 participants who had intentions to quit smoking within 6 months at baseline, 6 (24.0%) maintained their intention to quit smoking for 1 year, and 16 (64.0%) did not maintain their intention to quit smoking.

Conclusions

Our findings showed that many smokers with schizophrenia were interested in quitting smoking, but few patients received treatment and actually quit smoking. Timely intervention, including the option to receive smoking cessation treatment, is necessary for those patients with schizophrenia who smoke.

Trial registration

UMIN Clinical Trials Registry (UMIN000023874, registered on August 31, 2016).
Literature
1.
go back to reference de Leon J, Becona E, Gurpegui M, Gonzalez-Pinto A, Diaz FJ. The association between high nicotine dependence and severe mental illness may be consistent across countries. J Clin Psychiatry. 2002;63(9):812–6.CrossRef de Leon J, Becona E, Gurpegui M, Gonzalez-Pinto A, Diaz FJ. The association between high nicotine dependence and severe mental illness may be consistent across countries. J Clin Psychiatry. 2002;63(9):812–6.CrossRef
2.
go back to reference Wang YY, Wang S, Zheng W, Zhong BL, Ng CH, Ungvari GS, Wang CX, Xiang YT, Li XH. Cognitive functions in smoking and non-smoking patients with schizophrenia: a systematic review and meta-analysis of comparative studies. Psychiatry Res. 2019;272:155–63.CrossRef Wang YY, Wang S, Zheng W, Zhong BL, Ng CH, Ungvari GS, Wang CX, Xiang YT, Li XH. Cognitive functions in smoking and non-smoking patients with schizophrenia: a systematic review and meta-analysis of comparative studies. Psychiatry Res. 2019;272:155–63.CrossRef
3.
go back to reference Sagud M, Mihaljevic Peles A, Pivac N. Smoking in schizophrenia: recent findings about an old problem. Curr Opin Psychiatry. 2019;32(5):402–8.CrossRef Sagud M, Mihaljevic Peles A, Pivac N. Smoking in schizophrenia: recent findings about an old problem. Curr Opin Psychiatry. 2019;32(5):402–8.CrossRef
4.
go back to reference de Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res. 2005;76(2–3):135–57.CrossRef de Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res. 2005;76(2–3):135–57.CrossRef
5.
go back to reference Ohi K, Shimada T, Kuwata A, Kataoka Y, Okubo H, Kimura K, Yasuyama T, Uehara T, Kawasaki Y. Smoking rates and number of cigarettes smoked per day in schizophrenia: a large cohort meta-analysis in a Japanese population. Int J Neuropsychopharmacol. 2019;22(1):19–27.CrossRef Ohi K, Shimada T, Kuwata A, Kataoka Y, Okubo H, Kimura K, Yasuyama T, Uehara T, Kawasaki Y. Smoking rates and number of cigarettes smoked per day in schizophrenia: a large cohort meta-analysis in a Japanese population. Int J Neuropsychopharmacol. 2019;22(1):19–27.CrossRef
6.
go back to reference Crump C, Winkleby MA, Sundquist K, Sundquist J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry. 2013;170(3):324–33.CrossRef Crump C, Winkleby MA, Sundquist K, Sundquist J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry. 2013;170(3):324–33.CrossRef
7.
go back to reference Sankaranarayanan A, Mancuso S, Wilding H, Ghuloum S, Castle D. Smoking, Suicidality and psychosis: a systematic meta-analysis. PLoS One. 2015;10(9):e0138147.CrossRef Sankaranarayanan A, Mancuso S, Wilding H, Ghuloum S, Castle D. Smoking, Suicidality and psychosis: a systematic meta-analysis. PLoS One. 2015;10(9):e0138147.CrossRef
8.
go back to reference Sharma R, Gartner CE, Hall WD. The challenge of reducing smoking in people with serious mental illness. Lancet Respir Med. 2016;4(10):835–44.CrossRef Sharma R, Gartner CE, Hall WD. The challenge of reducing smoking in people with serious mental illness. Lancet Respir Med. 2016;4(10):835–44.CrossRef
9.
go back to reference Cook BL, Wayne GF, Kafali EN, Liu Z, Shu C, Flores M. Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation. JAMA. 2014;311(2):172–82.CrossRef Cook BL, Wayne GF, Kafali EN, Liu Z, Shu C, Flores M. Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation. JAMA. 2014;311(2):172–82.CrossRef
10.
go back to reference GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389(10082):1885–906.CrossRef GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389(10082):1885–906.CrossRef
11.
go back to reference Prochaska JJ, Das S, Young-Wolff KC. Smoking, mental illness, and public health. Annu Rev Public Health. 2017;38:165–85.CrossRef Prochaska JJ, Das S, Young-Wolff KC. Smoking, mental illness, and public health. Annu Rev Public Health. 2017;38:165–85.CrossRef
12.
go back to reference Tidey JW, Miller ME. Smoking cessation and reduction in people with chronic mental illness. BMJ. 2015;351:h4065.CrossRef Tidey JW, Miller ME. Smoking cessation and reduction in people with chronic mental illness. BMJ. 2015;351:h4065.CrossRef
13.
go back to reference Prochaska JJ. Smoking and mental illness--breaking the link. N Engl J Med. 2011;365(3):196–8.CrossRef Prochaska JJ. Smoking and mental illness--breaking the link. N Engl J Med. 2011;365(3):196–8.CrossRef
14.
go back to reference Schroeder SA. Smoking cessation should be an integral part of serious mental illness treatment. World Psychiatry. 2016;15(2):175–6.CrossRef Schroeder SA. Smoking cessation should be an integral part of serious mental illness treatment. World Psychiatry. 2016;15(2):175–6.CrossRef
15.
go back to reference Poland B, Frohlich K, Haines RJ, Mykhalovskiy E, Rock M, Sparks R. The social context of smoking: the next frontier in tobacco control? Tob Control. 2006;15(1):59–63.CrossRef Poland B, Frohlich K, Haines RJ, Mykhalovskiy E, Rock M, Sparks R. The social context of smoking: the next frontier in tobacco control? Tob Control. 2006;15(1):59–63.CrossRef
17.
go back to reference Fujiwara M, Inagaki M, Nakaya N, Fujimori M, Higuchi Y, Kakeda K, Uchitomi Y, Yamada N. Smoking among adults with serious psychological distress: analysis of anonymized data from a national cross-sectional survey in Japan. J Affect Disord. 2018;239:131–7.CrossRef Fujiwara M, Inagaki M, Nakaya N, Fujimori M, Higuchi Y, Kakeda K, Uchitomi Y, Yamada N. Smoking among adults with serious psychological distress: analysis of anonymized data from a national cross-sectional survey in Japan. J Affect Disord. 2018;239:131–7.CrossRef
18.
go back to reference Kure S, Kashida G. The state of private confinement and its statistical observation of the mentally ill: modern translation. (in Japanese). Tokyo: Igakushoin; 2012. Kure S, Kashida G. The state of private confinement and its statistical observation of the mentally ill: modern translation. (in Japanese). Tokyo: Igakushoin; 2012.
19.
go back to reference Hashimoto K, Makinodan M, Matsuda Y, Morimoto T, Ueda S, Kishimoto T. Smoking bans in mental health hospitals in Japan: barriers to implementation. Ann General Psychiatry. 2015;14:35.CrossRef Hashimoto K, Makinodan M, Matsuda Y, Morimoto T, Ueda S, Kishimoto T. Smoking bans in mental health hospitals in Japan: barriers to implementation. Ann General Psychiatry. 2015;14:35.CrossRef
20.
go back to reference Fujiwara M, Inagaki M, Nakaya N, Fujimori M, Higuchi Y, Hayashibara C, So R, Kakeda K, Kodama M, Uchitomi Y, et al. Cancer screening participation in schizophrenic outpatients and the influence of their functional disability on the screening rate: a cross-sectional study in Japan. Psychiatry Clin Neurosci. 2017;71(12):813–25.CrossRef Fujiwara M, Inagaki M, Nakaya N, Fujimori M, Higuchi Y, Hayashibara C, So R, Kakeda K, Kodama M, Uchitomi Y, et al. Cancer screening participation in schizophrenic outpatients and the influence of their functional disability on the screening rate: a cross-sectional study in Japan. Psychiatry Clin Neurosci. 2017;71(12):813–25.CrossRef
21.
go back to reference American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition. Washington, DC: American Psychiatric Association; 2013.CrossRef American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition. Washington, DC: American Psychiatric Association; 2013.CrossRef
22.
go back to reference World Health Organization. Guidelines for Controlling and Monitoring the Tobacco Epidemic: World Health Organization; 1998. World Health Organization. Guidelines for Controlling and Monitoring the Tobacco Epidemic: World Health Organization; 1998.
23.
go back to reference Nakamura M, Masui S, Oshima A, Okayama A, Ueshima H, Group HR. Effects of stage-matched repeated individual counseling on smoking cessation: a randomized controlled trial for the high-risk strategy by lifestyle modification (HISLIM) study. Environ Health Prevent Med. 2004;9(4):152–60.CrossRef Nakamura M, Masui S, Oshima A, Okayama A, Ueshima H, Group HR. Effects of stage-matched repeated individual counseling on smoking cessation: a randomized controlled trial for the high-risk strategy by lifestyle modification (HISLIM) study. Environ Health Prevent Med. 2004;9(4):152–60.CrossRef
24.
go back to reference Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983;51(3):390–5.CrossRef Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983;51(3):390–5.CrossRef
25.
go back to reference Prochaska JO, Velicer WF. Misinterpretations and misapplications of the transtheoretical model. Am J Health Promot. 1997;12(1):11–2.CrossRef Prochaska JO, Velicer WF. Misinterpretations and misapplications of the transtheoretical model. Am J Health Promot. 1997;12(1):11–2.CrossRef
26.
go back to reference Dijkstra A, Roijackers J, De Vries H. Smokers in four stages of readiness to change. Addict Behav. 1998;23(3):339–50.CrossRef Dijkstra A, Roijackers J, De Vries H. Smokers in four stages of readiness to change. Addict Behav. 1998;23(3):339–50.CrossRef
27.
go back to reference Cokkinides VE, Ward E, Jemal A, Thun MJ. Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med. 2005;28(1):119–22.CrossRef Cokkinides VE, Ward E, Jemal A, Thun MJ. Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med. 2005;28(1):119–22.CrossRef
28.
go back to reference Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989;84(7):791–9.CrossRef Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989;84(7):791–9.CrossRef
29.
go back to reference Etter JF, Duc TV, Perneger TV. Validity of the Fagerstrom test for nicotine dependence and of the heaviness of smoking index among relatively light smokers. Addiction. 1999;94(2):269–81.CrossRef Etter JF, Duc TV, Perneger TV. Validity of the Fagerstrom test for nicotine dependence and of the heaviness of smoking index among relatively light smokers. Addiction. 1999;94(2):269–81.CrossRef
30.
go back to reference Perez-Rios M, Santiago-Perez MI, Alonso B, Malvar A, Hervada X, de Leon J. Fagerstrom test for nicotine dependence vs heavy smoking index in a general population survey. BMC Public Health. 2009;9:493.CrossRef Perez-Rios M, Santiago-Perez MI, Alonso B, Malvar A, Hervada X, de Leon J. Fagerstrom test for nicotine dependence vs heavy smoking index in a general population survey. BMC Public Health. 2009;9:493.CrossRef
32.
go back to reference Baker A, Richmond R, Lewin TJ, Kay-Lambkin F. Cigarette smoking and psychosis: naturalistic follow up 4 years after an intervention trial. Aust N Z J Psychiatry. 2010;44(4):342–50.CrossRef Baker A, Richmond R, Lewin TJ, Kay-Lambkin F. Cigarette smoking and psychosis: naturalistic follow up 4 years after an intervention trial. Aust N Z J Psychiatry. 2010;44(4):342–50.CrossRef
33.
go back to reference Cather C, Pachas GN, Cieslak KM, Evins AE. Achieving smoking cessation in individuals with schizophrenia: special considerations. CNS Drugs. 2017;31(6):471–81.CrossRef Cather C, Pachas GN, Cieslak KM, Evins AE. Achieving smoking cessation in individuals with schizophrenia: special considerations. CNS Drugs. 2017;31(6):471–81.CrossRef
34.
go back to reference Noar SM, Benac CN, Harris MS. Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions. Psychol Bull. 2007;133(4):673–93.CrossRef Noar SM, Benac CN, Harris MS. Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions. Psychol Bull. 2007;133(4):673–93.CrossRef
35.
go back to reference Riemsma RP, Pattenden J, Bridle C, Sowden AJ, Mather L, Watt IS, Walker A. Systematic review of the effectiveness of stage based interventions to promote smoking cessation. BMJ. 2003;326(7400):1175–7.CrossRef Riemsma RP, Pattenden J, Bridle C, Sowden AJ, Mather L, Watt IS, Walker A. Systematic review of the effectiveness of stage based interventions to promote smoking cessation. BMJ. 2003;326(7400):1175–7.CrossRef
36.
go back to reference Nakamura M. Article 14 of the World Health Organization framework convention on tobacco control: demanding reduction measures concerning tobacco dependence and cessation. (in Japanese). Hoken Iryo Kagaku. 2015;64(5):475–83. Nakamura M. Article 14 of the World Health Organization framework convention on tobacco control: demanding reduction measures concerning tobacco dependence and cessation. (in Japanese). Hoken Iryo Kagaku. 2015;64(5):475–83.
37.
go back to reference Ahmed S, Virani S, Kotapati VP, Bachu R, Adnan M, Khan AM, Zubair A, Begum G, Kumar J, Qureshi M, et al. Efficacy and safety of Varenicline for smoking cessation in schizophrenia: a meta-analysis. Front Psychiatry. 2018;9:428.CrossRef Ahmed S, Virani S, Kotapati VP, Bachu R, Adnan M, Khan AM, Zubair A, Begum G, Kumar J, Qureshi M, et al. Efficacy and safety of Varenicline for smoking cessation in schizophrenia: a meta-analysis. Front Psychiatry. 2018;9:428.CrossRef
38.
go back to reference Leischow SJ. Increasing smoking cessation in the United States: expanding the availability of over-the-counter medications. JAMA. 2019;321(6):541–2.CrossRef Leischow SJ. Increasing smoking cessation in the United States: expanding the availability of over-the-counter medications. JAMA. 2019;321(6):541–2.CrossRef
39.
go back to reference Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev. 2013;2:CD007253. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev. 2013;2:CD007253.
40.
go back to reference Smith PH, Zhang J, Weinberger AH, Mazure CM, McKee SA. Gender differences in the real-world effectiveness of smoking cessation medications: findings from the 2010-2011 tobacco use supplement to the current population survey. Drug Alcohol Depend. 2017;178:485–91.CrossRef Smith PH, Zhang J, Weinberger AH, Mazure CM, McKee SA. Gender differences in the real-world effectiveness of smoking cessation medications: findings from the 2010-2011 tobacco use supplement to the current population survey. Drug Alcohol Depend. 2017;178:485–91.CrossRef
41.
go back to reference Igarashi A, Negishi S, Goto R, Suwa K. Web-based survey on smoking cessation behaviors of current and former smokers in Japan. Curr Med Res Opin. 2014;30(10):1911–21.CrossRef Igarashi A, Negishi S, Goto R, Suwa K. Web-based survey on smoking cessation behaviors of current and former smokers in Japan. Curr Med Res Opin. 2014;30(10):1911–21.CrossRef
43.
go back to reference Takeuchi T, Nakao M, Shinozaki Y, Yano E. Validity of self-reported smoking in schizophrenia patients. Psychiatry Clin Neurosci. 2010;64(3):274–8.CrossRef Takeuchi T, Nakao M, Shinozaki Y, Yano E. Validity of self-reported smoking in schizophrenia patients. Psychiatry Clin Neurosci. 2010;64(3):274–8.CrossRef
44.
go back to reference Takeuchi T, Nakao M, Shinozaki Y, Yano E. Validity of the self-reported smoking status of schizophrenia patients, taking gender-related differences into consideration. Int J Psychiatry Clin Pract. 2010;14(4):282–6.CrossRef Takeuchi T, Nakao M, Shinozaki Y, Yano E. Validity of the self-reported smoking status of schizophrenia patients, taking gender-related differences into consideration. Int J Psychiatry Clin Pract. 2010;14(4):282–6.CrossRef
Metadata
Title
Change in smoking cessation stage over 1 year in patients with schizophrenia: a follow up study in Japan
Authors
Yuji Higuchi
Masaki Fujiwara
Naoki Nakaya
Maiko Fujimori
Chinatsu Hayashibara
Ryuhei So
Ikuta Shinkawa
Kojiro Sato
Yuji Yada
Masafumi Kodama
Hiroshi Takenaka
Yoshiki Kishi
Kyoko Kakeda
Yosuke Uchitomi
Norihito Yamada
Masatoshi Inagaki
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Schizophrenia
Published in
BMC Psychiatry / Issue 1/2019
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-019-2351-9

Other articles of this Issue 1/2019

BMC Psychiatry 1/2019 Go to the issue